Ignite Creation Date:
2025-12-25 @ 12:40 AM
Ignite Modification Date:
2026-03-05 @ 2:50 PM
Study NCT ID:
NCT03010267
Status:
COMPLETED
Last Update Posted:
2017-06-05
First Post:
2017-01-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
DP-R213 Phase 1 Pharmacokinetics Study
Sponsor:
Alvogen Korea
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
DP-CTR213-I-04
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None